Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled.

Mutual Advisors LLC lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.9% in the 3rd quarter, according to its most recent Form 13F filing with the ...

Since its formation, Thermo Fisher Scientific Inc. (NYSE:TMO) has experienced substantial growth, driven primarily by a series of strategic acquisitions, including the likes of Life Technologies ...

On Tuesday, Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $547.77 which represents a decrease of $-4.77 or -0.86% from the prior close of $552.54. The stock opened at $550.

Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a prominent American company in biotech and life sciences, offers a diverse range ...

Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

Mount Yale Investment Advisors LLC lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 23.0% ...

For the full year 2024, Thermo Fisher raised the lower end of its adjusted EPS guidance to a new range of $21.35 to $22.07, ...

Thermo Fisher Scientific (TMO) announced earnings for third quarter that decreased from last year but beat the Street estimates.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts expect Thermo Fisher Scientific to report an earnings per share (EPS) of $5.25. The market awaits Thermo Fisher Scientific's announcement, with hopes high for news of surpassing estimates and ...